Product Images Nubeqa
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 4 images provide visual information about the product associated with Nubeqa NDC 50419-395 by Bayer Healthcare Pharmaceuticals Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
chemical structure - image 01
plan Meier Curve Metastases Free Survival - image 02
This appears to be a table with data related to Metastasis Free Survival Probability for patients taking NUBEQA and Placebo. It includes the number of patients in each group, censorship information, and patients at risk over a period of months from randomization. There is no additional context or information available.*
NUBEQA 300 mg label - image 03
The text contains a mix of readable text and non-readable characters, so it is not possible to generate a useful description.*
image 04
This appears to be a graph showing Overall Survival Probability for NUBEQA vs Placebo as well as the number of patients at risk over time. The graph presents the data at different time intervals, starting from 24 months up to 60 months, and displays the percentage of overall survival probability for both NUBEQA (955) and Placebo (554) groups. Patients at risk are also presented on the graph. It's unclear what the numbers on top - 100, 90, 80, 60, 50, 30, 20, and 10 represent, but they might be showing the probability of the disease persisting at different stages.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.